cyclosporine has been researched along with Cardiomyopathy, Chagas in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellotti, G; Bocchi, EA; de Lourdes Higuchi, M; Fiorelli, A; Jatene, A; Kalil, J; Pilleggi, F; Stolf, N; Uip, D | 1 |
Amato-Neto, V; Bacal, F; Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, AD; Mocelin, AO; Pileggi, F; Stolf, NA; Uip, D | 1 |
Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML | 1 |
3 other study(ies) available for cyclosporine and Cardiomyopathy, Chagas
Article | Year |
---|---|
Long-term follow-up after heart transplantation in Chagas' disease.
Topics: Actuarial Analysis; Adrenal Cortex Hormones; Adult; Azathioprine; Chagas Cardiomyopathy; Chagas Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Male; Necrosis; Nitroimidazoles; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Trypanocidal Agents | 1993 |
Heart transplantation for chronic Chagas' heart disease.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Cause of Death; Chagas Cardiomyopathy; Child; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoma; Male; Methylprednisolone; Middle Aged; Myocarditis; Parasitemia; Prednisone; Recurrence; Sarcoma, Kaposi; Survival Rate; Treatment Outcome | 1996 |
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents | 1998 |